A groundbreaking study has introduced a DNA-centric strategy aimed at enhancing site-specific recombination through the engineering of chimeric attachment sites. This advancement is particularly notable for its application in both human cells and plant systems, where it has demonstrated remarkable efficiency.
Key Discoveries in Recombination Efficiency
The research focused on optimizing the integration efficiency of the Bxb1 recombinase, a tool that facilitates precise DNA recombination. Among the engineered variants, the attB(V111) site achieved an impressive 51.9% integration efficiency in HEK293T cells, which is 1.7 times greater than the wild-type attB. In rice protoplasts, the integration efficiency reached 35.6%, marking a 4.4-fold increase compared to the wild-type.
Methodology and Validation
The study employed a systematic approach to design 144 attB variants based on the canonical attachment consensus. By rationally combining favorable sequence elements from known natural recognition sites, the researchers created high-activity chimeric attachment sites that bypassed the need for extensive random screening. This method allowed for the identification of hyperactive variants capable of driving efficient targeted integration.
In human cells, these engineered variants facilitated the integration of therapeutic constructs, including a CD19 chimeric antigen receptor and an ornithine transcarbamylase expression cassette, achieving integration efficiencies of 31% and 25%, respectively. In rice, the engineered variants enabled the integration of a 5.8 kb herbicide-resistance cassette at a targeted genomic locus, with stable integration observed in 24% of regenerated plants.
Implications for Genetic Engineering
The findings were validated through Oxford Nanopore-based long-read sequencing, which confirmed precise insertions with high specificity. The propagation of edited seedlings to T1 plants demonstrated that the edits were heritable, indicating a stable modification that could be passed to future generations.
This innovative approach presents a broadly applicable method for recombinase-based genome editing, enhancing the potential for advancements in cell and gene therapy, as well as in plant breeding and synthetic biology.
This article was produced by NeonPulse.today using human and AI-assisted editorial processes, based on publicly available information. Content may be edited for clarity and style.
